Updated scar management practical guidelines: non-invasive and invasive measures - PubMed

Affiliations

• PMID: 24888226
• DOI: 10.1016/j.bjps.2014.04.011

Free article

Review

Updated scar management practical guidelines: non-invasive and invasive measures

Stan Monstrey et al. J Plast Reconstr Aesthet Surg. 2014 Aug.

Free article

Abstract

Hypertrophic scars and keloids can be aesthetically displeasing and lead to severe psychosocial impairment. Many invasive and non-invasive options are available for the plastic (and any other) surgeon both to prevent and to treat abnormal scar formation. Recently, an updated set of practical evidence-based guidelines for the management of hypertrophic scars and keloids was developed by an international group of 24 experts from a wide range of specialities. An initial set of strategies to minimize the risk of scar formation is applicable to all types of scars and is indicated before, during and immediately after surgery. In addition to optimal surgical management, this includes measures to reduce skin tension, and to provide taping, hydration and ultraviolet (UV) protection of the early scar tissue. Silicone sheeting or gel is universally considered as the first-line prophylactic and treatment option for hypertrophic scars and keloids. The efficacy and safety of this gold-standard, non-invasive therapy has been demonstrated in many clinical studies. Other (more specialized) scar treatment options are available for high-risk patients and/or scars. Pressure garments may be indicated for more widespread scarring, especially after burns. At a later stage, more invasive or surgical procedures may be necessary for the correction of permanent unaesthetic scars and can be combined with adjuvant measures to achieve optimal outcomes. The choice of scar management measures for a particular patient should be based on the newly updated evidence-based recommendations taking individual patient and wound characteristics into consideration.

Keywords: Guideline; Plastic surgeon; Scar; Silicone; Surgery.

Similar articles

• Management of scars: updated practical guidelines and use of silicones.

  Meaume S, Le Pillouer-Prost A, Richert B, Roseeuw D, Vadoud J. Meaume S, et al. Eur J Dermatol. 2014 Jul-Aug;24(4):435-43. doi: 10.1684/ejd.2014.2356. Eur J Dermatol. 2014. PMID: 25141160 Review.

• [International clinical recommendations on scar management].

  Ziegler UE. Ziegler UE. Zentralbl Chir. 2004 Aug;129(4):296-306. doi: 10.1055/s-2004-822830. Zentralbl Chir. 2004. PMID: 15354252 Review. German.

• Management of keloids and hypertrophic scars.

  Juckett G, Hartman-Adams H. Juckett G, et al. Am Fam Physician. 2009 Aug 1;80(3):253-60. Am Fam Physician. 2009. PMID: 19621835 Review.

• Intralesional treatment for keloids and hypertrophic scars: a review.

  Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Ledon JA, et al. Dermatol Surg. 2013 Dec;39(12):1745-57. doi: 10.1111/dsu.12346. Epub 2013 Nov 13. Dermatol Surg. 2013. PMID: 24299571 Review.

• [Current methods of treatment and prevention of pathologic scars].

  Kelemen O, Kollár L. Kelemen O, et al. Magy Seb. 2007 Apr;60(2):63-70. doi: 10.1556/MaSeb.60.2007.2.1. Magy Seb. 2007. PMID: 17649846 Review. Hungarian.

Cited by

• Identification and characterization of four immune-related signatures in keloid.

  Wang X, Liang B, Li J, Pi X, Zhang P, Zhou X, Chen X, Zhou S, Yang R. Wang X, et al. Front Immunol. 2022 Jul 27;13:942446. doi: 10.3389/fimmu.2022.942446. eCollection 2022. Front Immunol. 2022. PMID: 35967426 Free PMC article.

• No Differences in Wound Healing and Scar Formation Were Observed in Patients With Different COVID-19 Vaccination Intervals.

  Dong C, Yu Z, Quan X, Wei S, Wang J, Ma X. Dong C, et al. Front Public Health. 2022 Jun 1;10:883113. doi: 10.3389/fpubh.2022.883113. eCollection 2022. Front Public Health. 2022. PMID: 35719612 Free PMC article.

• Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids.

  Pavelecini M, Zettler CG, Fernandes MC, Ely PB. Pavelecini M, et al. Plast Reconstr Surg Glob Open. 2019 Feb 12;7(2):e2030. doi: 10.1097/GOX.0000000000002030. eCollection 2019 Feb. Plast Reconstr Surg Glob Open. 2019. PMID: 30881820 Free PMC article.

• Prevalence, Clinical Significance and Risk Factors for Developing Scar Pain and Sensibility Disorders in Breast Cancer Patients after Breast-Conserving Therapy and Mastectomy.

  Dieterich M, Allmendinger S, Gerber B, Reimer T, Hartmann S, Stachs A, Stubert J. Dieterich M, et al. Breast Care (Basel). 2021 Oct;16(5):507-515. doi: 10.1159/000513241. Epub 2020 Dec 30. Breast Care (Basel). 2021. PMID: 34720810 Free PMC article.

• A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.

  Grek CL, Montgomery J, Sharma M, Ravi A, Rajkumar JS, Moyer KE, Gourdie RG, Ghatnekar GS. Grek CL, et al. J Invest Dermatol. 2017 Mar;137(3):620-630. doi: 10.1016/j.jid.2016.11.006. Epub 2016 Nov 14. J Invest Dermatol. 2017. PMID: 27856288 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information